JETBLUE AIRWAYS CORP·4

Mar 12, 9:25 PM ET

Winkelmann Thomas 4

4 · JETBLUE AIRWAYS CORP · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

JetBlue Director Thomas Winkelmann Exercises Options, Receives DSUs

What Happened
Thomas Winkelmann, a director of JetBlue Airways (JBLU), had activity on March 10, 2026: an exercise/conversion of 22,094 derivative shares (transaction code M) and a concurrent disposition of the same 22,094 shares, and he was granted 29,867 deferred/derivative stock units (transaction code A). The filing lists no per-share prices or total dollar values (prices shown as N/A).

Key Details

  • Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely within the two-business-day window).
  • Exercise/conversion (M): 22,094 shares acquired and a simultaneous disposition of 22,094 shares (both reported as derivative transactions). No price or value reported.
  • Grant/award (A): 29,867 deferred stock units (DSUs) awarded; reported as derivative/award, price N/A.
  • Shares owned after the transactions: not specified in the filing.
  • Relevant footnotes from the filing:
    • F1: Upon vesting, restricted stock units convert 1:1 into common shares.
    • F2: DSUs entitle the holder to one share per unit upon vesting; settlement of vested DSUs occurs six months after the director leaves the board; the annual DSU grant vests on the one-year anniversary.
    • F3: These DSUs vest over one year starting from vesting commencement date March 10, 2026.
    • F4: Director restricted stock units referenced vest on the one-year anniversary of March 10, 2025 (i.e., March 10, 2026).
  • No 10b5-1 plan, tax-withholding method, or sale proceeds are specified in the filing.

Context
A simultaneous acquisition and disposition of the same number of shares following an exercise commonly reflects net-share settlement or shares surrendered to cover taxes rather than an outright market sale; the filing here shows both the acquisition and disposition but does not state the precise mechanism. The 29,867 DSUs are grants (not open-market purchases) and will vest/settle according to the DSU terms noted above. These actions are routine director compensation and do not by themselves indicate the director’s market view.

Insider Transaction Report

Form 4
Period: 2026-03-10
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-10+22,09435,473 total
  • Award

    Deferred Stock Units

    [F2][F3]
    2026-03-10+29,867112,764 total
    Common Stock (29,867 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F4]
    2026-03-1022,0940 total
    Common Stock (22,094 underlying)
Footnotes (4)
  • [F1]Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.
  • [F2]This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.
  • [F3]The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2026.
  • [F4]The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.
Signature
/s/ Shannon Collins, as Attorney-in-Fact|2026-03-12

Documents

1 file
  • 4
    wk-form4_1773365126.xmlPrimary

    FORM 4